CVS logo

CVS

CVS Health Corporation

$73.15
+$1.01(+1.40%)
75
Overall
100
Value
50
Tech
--
Quality
Market Cap
$90.75B
Volume
6.39M
52W Range
$43.56 - $73.23
Target Price
$81.55
Order:

Income Statement

MetricTrendChart
2015
Dec
2016
Dec
2017
Dec
2018
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
$153.3B$177.5B$184.8B$193.9B$255.8B$267.9B$290.9B$85.3B$99.2B$122.9B
Total Revenue
$153.3B$177.5B$184.8B$194.6B$256.8B$268.7B$292.1B$322.5B$357.8B$372.8B
COST OF GOODS SOLD
Cost of Revenue
$126.8B$148.7B$153.4B$156.4B$158.7B$219.7B$240.0B$196.9B$217.1B$206.3B
GROSS PROFIT
Gross Profit
$26.5B$28.9B$31.3B$38.1B$98.1B$49.0B$52.1B$125.6B$140.7B$166.5B
OPERATING EXPENSES
Operating Expenses
$17.1B$18.5B$18.8B$21.4B$-4.0M$-3.0M$-3.0M$38.2B$126.1B$41.6B
Selling, General & Administrative
$126.8B$148.7B--$6.6B------------
Selling & Marketing Expenses
$221.0M$216.0M$230.0M$364.0M$396.0M$461.0M$707.0M$745.0M$985.0M$989.0M
General & Administrative Expenses
$-22.0M$-24.0M$153.0M$141.0M$111.0M----------
Promotion & Advertising
$221.0M$216.0M$230.0M$364.0M$396.0M$461.0M$707.0M------
Salaries & Wages
$-26.0M$-22.0M----------------
Depreciation & Amortization
$2.1B$2.5B$2.5B$2.7B$4.4B$4.4B$4.5B$4.2B$4.4B$4.6B
Depreciation & Amortization
$126.8B$2.5B$156.2B$2.7B$4.4B$4.4B$4.5B--$86.2B--
Amortization
$38.1B$38.2B$38.5B$-398.0M$79.8B$-449.0M$79.2B$78.4B$91.5B$91.6B
Other Operating Expenses
$17.1B$18.5B$18.8B$21.4B$-4.0M$-3.0M$-3.0M$38.2B$39.8B$41.6B
OPERATING INCOME
Operating income
$9.5B$10.4B$9.5B$4.0B$12.0B$13.9B$13.2B$8.0B$13.7B$8.5B
EBITDA
$11.5B$12.2B$11.8B$6.7B$16.4B$17.1B$17.5B$12.3B$18.2B$13.7B
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
$838.0M$1.1B$1.1B$2.6B$3.0B$2.9B$2.5B$2.3B$2.7B$3.0B
Intinc
$21.0M$20.0M$21.0M--------------
Net Non-Operating Interest Income/Expense
$-838.0M$-1.1B$-1.1B$-2.6B$-3.0B$-2.9B$-2.5B$-2.3B$-73.0M$-71.0M
Gain on Sale of Securities
----$21.0M$660.0M$1.0B$798.0M$1.2B$838.0M$1.2B$2.2B
Other Income/Expense
$-27.7B$149.3B$3.0B$5.9B$51.5B$56.1B$63.3B$72.6B$-892.0M$-2.7B
Other Special Charges
$27.7B$-671.0M$-208.0M$-6.6B$-52.5B$-56.9B$-64.5B$-70.9B$88.0M$590.0M
SPECIAL ITEMS
Restructring And Mn A Income
----$-6.8B$-1.2B--------$507.0M$1.2B
Special Income Charges
----$-181.0M$-6.1B$24.0M--$-431.0M$-5.8B$-507.0M$-1.3B
Impairment of Capital Assets
----$181.0M$6.1B----$431.0M--$152.0M--
PRE-TAX INCOME
EBIT
$9.5B$9.7B$9.3B$4.0B$12.0B$12.7B$13.0B$8.1B$13.8B$9.1B
Pre-Tax Income
$8.6B$8.6B$8.3B$1.4B$9.0B$9.8B$10.4B$5.8B$11.2B$6.1B
INCOME TAX
Tax Provision
$3.4B$3.3B$1.6B$2.0B$2.4B$2.6B$2.5B$1.5B$2.8B$1.6B
NET INCOME
Net Income
$5.2B$5.3B$6.6B$-594.0M$6.6B$7.2B$8.0B$4.3B$8.3B$4.6B
Net Income (Continuing Operations)
$5.2B$5.3B$6.6B$-594.0M$6.6B$7.2B$7.9B$4.3B$8.4B$4.6B
Net Income (Discontinued Operations)
$5.2B$5.3B$6.6B$-594.0M$6.6B$7.2B$8.0B$4.3B$8.3B$4.6B
Net Income (Common Stockholders)
$5.2B$5.3B$6.6B$-594.0M$73.7B$7.2B$8.0B$4.3B$8.3B$4.6B
Normalized Income
$5.6B$5.6B$-234.4B$-237.2B$7.8B$7.5B--------
TOTALS
Total Expenses
$143.8B$167.2B$172.3B$177.8B$158.7B$164.0B$175.8B$235.1B$343.2B$247.9B
SHARE & EPS DATA
Average Shares Outstanding
$1.1B$1.1B$1.0B$1.0B$1.3B$1.3B$1.3B$1.3B$1.3B$1.3B
Average Shares Outstanding (Diluted)
$1.1B$1.1B$1.0B$1.0B$1.3B$1.3B$1.3B$1.3B$1.3B$1.3B
Shares Outstanding
$1.1B$1.0B$1.0B$1.3B$1.3B$1.3B$1.3B$1.3B$1.3B$1.3B
Basic EPS
$4.66$4.93$6.47$-0.57$5.1$5.48$6$3.16$6.49$3.67
Basic EPS (Continuing Operations)
$4.65$4.93$6.48$-0.57$5.1$5.49$6$3.16$6.49$3.67
Diluted EPS
$4.63$4.91$6.44$-0.57$5.08$5.46$5.95$3.14$6.47$3.66
Diluted EPS (Continuing Operations)
$4.62$4.91$6.45$-0.57$5.08$5.47$5.95$3.14$6.47$3.66
Dividend Per Share
$1.4$1.7$2$2$2$2$2$2.42$2.66$2.66
OTHER METRICS
Allowances For Construction
--$148.7B----------------
Basic Discontinuous Operations
$0.01--$-0.01----$-0.01--------
Depletion
$126.8B--$156.2B--------------
Diluted Discontinuous Operations
$0.01--$-0.01----$-0.01--------
Fees
------------------$-115.1B
Gain On Sale Of Business
------$86.0M$-205.0M$269.0M--------
Minority Interests
$-2.0M$-2.0M$-1.0M$2.0M$3.0M$-13.0M$12.0M$-16.0M$-24.0M$28.0M
Net Income Discontinuous Operations
$9.0M$-1.0M$-8.0M$-86.0M$-205.0M$-9.0M--------
Non Recurring Operation Expense
--------------$5.8B--$100.0M
Other Gain Loss From Disposition Of Discontinued Operations
$9.0M$-1.0M$-8.0M----$-9.0M--------
Other Gand A
$-22.0M$-24.0M$153.0M$141.0M$111.0M----------
Other Impairment Of Capital Assets
--------------$2.5B$349.0M--
Other Write Off
----$2.8B$37.0M$79.0M$-307.0M--------
Provision For Gain Loss On Disposal
------$-86.0M$-205.0M$269.0M--------
Rent And Landing Fees
$-22.0M$-24.0M$-24.0M$-21.0M------------
Selling Expense
--$148.7B--$6.6B------------
Write Down
--------$-24.0M----------
Restruct
----$-6.8B$-1.2B--------$507.0M$1.2B

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2CVS$73.15+1.4%6.39M
3
4
5
6

Get CVS Health Corporation Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.